Antiretroviral Therapy for Children and Newborns

Abstract

Abstract This chapter discusses advances in antiretroviral therapy for the prevention of mother-to-child HIV transmission. Pediatric-specific issues of early HIV diagnosis, timing and pathogenesis of HIV disease, and use of surrogate markers of HIV infection in this population are reviewed in the text. The difference between the concepts of HIV exposure and HIV infection is highlighted. The chapter concludes with a brief discussion citing the benefits of antiretroviral therapy in children.